Friday Update for 2020-10-23
Today we offer four items of Covid-19 news: a county-level dashboard of dangerousness; new discoveries on how the virus spreads so effectively and why it inhibits long-term immunity; and at-home saliva testing. Plus the accustomed frippery. Why illness may not … Continue reading →
Prophylactics, Therapeutics, and AstraZeneca
We have been writing about potential vaccines in late-stage trials — prophylactics intended to prevent Covid-19 disease and, ideally, infection with SARS-Cov-2. Another class of drugs is the therapeutics, such as the Regeneron “cocktail” the President received. The vaccines from … Continue reading →
Tuesday Update for 2020-10-20
The Update has gone semi-weekly. Herewith three more items of pandemic news you may have missed recently: the next pandemic; the duration of immunity; and two new metrics that may portend severe Covid-19. Plus a frippery. Two New Metrics That … Continue reading →
Friday Update for 2020-10-16
Herewith three items of Covid-19 news you may have missed this week: Pfizer’s timeline for EUA application, normally apolitical science publications criticize the Trump administration, and the $16T cost of the pandemic in the US. Plus the accustomed frippery. Pfizer … Continue reading →
Reinfection Redux
Repeat infections with Covid-19 are back in the news: a Nevada man’s case was published in The Lancet, and an elderly, immune-compromised woman in the Netherlands died after a second infection. Still, there is little cause to worry. We touched … Continue reading →
This is a group blog chronicling our new lives in the Twin Cities in the time of coronavirus social distancing, quarantine, working from home, and distance learning.
Would you like to add your voice to those of your neighbors who share notes here on how their lives are going in this suddenly tumultuous time?